RT Journal Article
SR Electronic
T1 Model-based spatial-temporal mapping of opisthorchiasis in endemic countries of Southeast Asia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.12.20126169
DO 10.1101/2020.06.12.20126169
A1 Zhao, Ting-Ting
A1 Feng, Yi-Jing
A1 Doanh, Pham Ngoc
A1 Sayasone, Somphou
A1 Khieu, Virak
A1 Nithikathkul, Choosak
A1 Qian, Men-Bao
A1 Hao, Yuan-Tao
A1 Lai, Ying-Si
YR 2020
UL http://medrxiv.org/content/early/2020/06/14/2020.06.12.20126169.abstract
AB Opisthorchiasis is an overlooked danger to Southeast Asia. High-resolution disease risk maps are critical for targeting control interventions to priority areas; however, they haven’t been available for Southeast Asia. A Bayesian spatial-temporal joint model was developed, where both point-referenced and area-level data were assumed to follow a binomial distribution, modeling with a logit regression in combination of potential influencing factors and spatial-temporal random effects. The model-based risk mapping identified area of high prevalence (>25%) of opisthorchiasis in northeastern Thailand, central-southern parts of Laos, and some eastern areas of Cambodia from 2010 onwards. And a total of 13.13 million (95% BCI: 11.43-15.21) people were infected with O. viverrini in 2018 in four major endemic countries (ie, Thailand, Laos, Cambodia, and Vietnam) of Southeast Asia, with a prevalence of 6.96% (95% BCI: 6.06%-8.06%). These model-based high-resolution risk maps can provide important information to guide the spatial targeting of opisthorchiasis control interventions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementYSL received financial support of the Sun Yat-Sen University One Hundred Talent Grant (http://rcb.sysu.edu.cn/). This study received financial support from the Natural Science Foundation of Guangdong Province (project no. 2017A030313704, http://gdstc.gd.gov.cn/), the National Natural Science Foundation of China (project no. 81703320, http://www.nsfc.gov.cn/), and the CMB Open Competition Program (project no. 17-274, https://chinamedicalboard.org/). Funders of this study were not involved in study design, data collection, data analysis, data interpretation, or writing of reports.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work was based on survey data pertaining to prevalence of opisthorchiasis extracted from open published peer-reviewed literatures. All data were aggregated and did not contain any information at individual or household levels. Therefore, there were no specific ethical issues warranted special attention.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.